For more LA stories like this, sign up for our new weekly newsletter, The Southland. You'll get features, profiles, histories ...
All five patients in a trial with recurrent glioblastoma given a combination of ImmunityBio's (NASDAQ:IBRX) natural killer (NK) cell therapy Anktiva and Novocure's (NASDAQ:NVCR) Optune Gio Tumor ...
Fully Equipped's Johnny Wunder and Jake Morrow are joined by Softspikes Charles Woodward to discuss how combo sets can improve your swing's efficiency. DC March Against Trump Draws Huge Turnout ...
Another cell therapy biotech has run out of steam, this time before ever reaching the clinic. California CAR-T company Appia Bio has closed up shop, founding CEO JeenJoo “JJ” Kang, Ph.D., wrote in an ...
The Trump administration’s abusive efforts to repurpose millions of federal records and funnel them into a centralized government database represent a systemic shift toward a consolidation of ...
Flying high after an FDA approval four months ago to treat generalized myasthenia gravis (gMG), Johnson & Johnson’s much-touted Imaavy (nipocalimab) has taken a hit, coming up short as part of a ...
News 10 This Morning's Olivea Herzberg details two programs at Central Texas College that helps students in and out of the classroom. News 10 This Morning's Olivea Herzberg details ongoing litigation ...
The Weather: It will be a cool and cloudy morning, but summer persists. You will see this evidence in the afternoon. Expect humidity and worse-than-normal air quality. ICE Used WA DOL Data: In spite ...